CRH
About: CRH is a global manufacturer of a range of building products used in construction projects, operating via a vertically integrated business model. The past decade has seen CRH transform into a leading building materials business, with increasing exposure to upstream building activities such as aggregates and cement. CRH's geographic footprint is mostly across developed markets. North America is CRH's largest market and accounts for 75% of EBITDA. The company is the largest producer of aggregates and asphalt in the US.
Employees: 79,800
0
Funds holding %
of 7,296 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
854% more call options, than puts
Call options by funds: $1.05B | Put options by funds: $110M
61% more first-time investments, than exits
New positions opened: 134 | Existing positions closed: 83
15% more repeat investments, than reductions
Existing positions increased: 342 | Existing positions reduced: 297
4% more funds holding
Funds holding: 822 [Q4 2024] → 851 (+29) [Q1 2025]
2.3% more ownership
Funds ownership: 77.33% [Q4 2024] → 79.63% (+2.3%) [Q1 2025]
2% less capital invested
Capital invested by funds: $48.6B [Q4 2024] → $47.4B (-$1.19B) [Q1 2025]
4% less funds holding in top 10
Funds holding in top 10: 50 [Q4 2024] → 48 (-2) [Q1 2025]
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$108
20%
upside
Avg. target
$111
23%
upside
High target
$114
27%
upside
2 analyst ratings
2 positive
100%
0 neutral
0%
0 negative
0%
RBC Capital Anthony Codling | 20%upside $108 | Outperform Maintained | 14 Apr 2025 |
Loop Capital Garik Shmois | 27%upside $114 | Buy Initiated | 9 Apr 2025 |
Financial journalist opinion
Neutral
Business Wire
4 days ago
CRH Medical Corporation and WovenX Announce Strategic Partnership to Advance GI Patient Access and Streamline Care Delivery
ATLANTA & CHICAGO--(BUSINESS WIRE)--CRH Medical Corporation (“CRH”), a leading provider of products and services for gastrointestinal (GI) providers and a wholly owned subsidiary of WELL Health Technologies Corp. (“WELL”), has announced a strategic partnership with WovenX Health (“WovenX”), a leader in integrated virtual specialty care. Together, they aim to deliver integrated, next-generation GI practice solutions designed to resolve persistent challenges surrounding patient access and operati.
Negative
Barrons
1 month ago
CRH Stock Falls Despite Solid Earings. Nothing Bad Has Happened—Yet.
Investors can take some solace in the outlook from construction giant CRH. It isn't seeing any negative impact from macroeconomic uncertainty yet.
Neutral
Seeking Alpha
1 month ago
CRH plc (CRH) Q1 2025 Earnings Call Transcript
CRH plc (NYSE:CRH ) Q1 2025 Earnings Conference Call May 6, 2025 8:00 AM ET Company Participants Conference Call Participants Operator Good day, and welcome to the CRH First Quarter 2025 Results Presentation. My name is Christa, and I will be your operator today.
Positive
Zacks Investment Research
1 month ago
CRH (CRH) Reports Q1 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for CRH (CRH) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Neutral
Business Wire
1 month ago
CRH plc (the "Company") Form 10-Q for the quarterly period ended March 31, 2025
NEW YORK--(BUSINESS WIRE)--A Form 10-Q for the quarterly period ended March 31, 2025 (the “Form 10-Q”) has been filed with the U.S. Securities and Exchange Commission (the "SEC") today. The Form 10-Q is available to view on the SEC's website at: https://www.sec.gov. and the Company's website at: https://www.crh.com.
Neutral
Business Wire
1 month ago
CRH Continues Share Buyback Program
NEW YORK--(BUSINESS WIRE)--CRH (NYSE: CRH), the leading provider of building materials solutions, is pleased to announce that it has completed the latest phase of its share buyback program, returning a further $0.3 billion of cash to shareholders. Between February 27, 2025 and May 2, 2025, 3.3 million ordinary shares listed on the New York Stock Exchange were repurchased. This brings total cash returned to shareholders under our ongoing share buyback program to $8.8 billion since its commenceme.
Neutral
Business Wire
1 month ago
CRH Q1 2025 Results
NEW YORK--(BUSINESS WIRE)--CRH (NYSE: CRH), a leading provider of building materials solutions, today reported first quarter 2025 financial results. Key Highlights Summary Financials Q1 2025 Change Total revenues $6.8bn +3% Net (loss) income ($98m) n/m1 Net (loss) income margin (1.5%) (320bps) Adjusted EBITDA* $495m +11% Adjusted EBITDA margin* 7.3% +50bps Diluted (loss) earnings per share ($0.15) n/m1 Good start to the year despite unfavorable weather in the seasonall.
Negative
Zacks Investment Research
1 month ago
CRH (CRH) Rises Yet Lags Behind Market: Some Facts Worth Knowing
The latest trading day saw CRH (CRH) settling at $93.46, representing a +0.45% change from its previous close.
Positive
Zacks Investment Research
1 month ago
CRH (CRH) Outperforms Broader Market: What You Need to Know
CRH (CRH) reachead $92.44 at the closing of the latest trading day, reflecting a +1.19% change compared to its last close.
Neutral
Business Wire
1 month ago
CRH Announces Date for Q1 2025 Results Conference Call
NEW YORK--(BUSINESS WIRE)--CRH (NYSE: CRH), the leading provider of building materials solutions, will publish its Q1 2025 financial results after the U.S. market closes on Monday, May 5, 2025 followed by a conference call and webcast presentation at 8:00 a.m. (EDT) on Tuesday, May 6, 2025. CRH's results and the related presentation will be available at www.crh.com/investors/results-presentations. Registration for the event can be made at www.crh.com/investors. Upon registration a link to join.
Charts implemented using Lightweight Charts™